Invesco
VOR icon

Invesco’s Vor Biopharma VOR Stock Holding History

Invesco’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
68,301
+56,701
+489% +$858K ﹤0.01% 2809
2026
Q1 		$207K Buy
+11,600
New +$164K ﹤0.01% 3476
2024
Q2 		– Sell
-869
Closed -$41.2K – 3976
2024
Q1 		$41.2K Sell
869
-33
-4% -$1.45K ﹤0.01% 3817
2023
Q4 		$40.6K Buy
902
+176
+24% +$7.26K ﹤0.01% 3764
2023
Q3 		$30.8K Hold
726
– – ﹤0.01% 3826
2023
Q2 		$44.9K Buy
+726
New +$66.3K ﹤0.01% 3823

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Invesco's VOR Position: Q2 2026 in Review

Invesco increased its Vor Biopharma (VOR) stake by 489% in Q2 2026, buying an estimated $858K and bringing the position to 68,301 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

Invesco first reported a position in VOR in Q2 2023 and has held it in 6 quarters since. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Invesco held 68,301 shares of Vor Biopharma worth $1.26M as of Q2 2026.
  • Invesco bought 56,701 Vor Biopharma shares in Q2 2026, an estimated $858K.
  • Vor Biopharma made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2809 holding.
  • Invesco first reported a position in Vor Biopharma in Q2 2023 and has held it in 6 quarters since.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.